FDA Clearance Tracker · K210958
i-STAT CHEM8+ cartridge with the i-STAT 1 System
Last checked: Nov 19, 2026Latest source record: Aug 13, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Aug 13, 2021
Substantially Equivalent
Time to decision
135 days
Received Mar 31, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K210958
- Device name
- i-STAT CHEM8+ cartridge with the i-STAT 1 System
- Applicant
- Abbott Point of Care, Inc.
- Applicant location
- Princton, NJ
- Received
- Mar 31, 2021
- Decided
- Aug 13, 2021
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Glucose Oxidase, Glucose (CGA)
- Device class
- Class II
- Regulation
- 21 CFR 862.1345
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code CGA. The earliest in FDA's data is K760347, decided Oct 5, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K210958
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Abbott Point of Care, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261039 · Decided Jun 26, 2026 · 88 days after receipt
Device type: Electrode, Ion Based, Enzymatic, Creatinine (CGL) · Laboratory Medicine & Pathology
K253051 · Decided Jun 11, 2026 · 262 days after receipt
Device type: Immunoassay Method, Troponin Subunit (MMI) · Laboratory Medicine & Pathology
K244014 · Decided May 2, 2025 · 127 days after receipt
Device type: Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph (CHL) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.